It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 4 TA indicator(s) are bullish.
ALC (@Pharmaceuticals: Other) experienced а -3.20% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.84%. For the same industry, the average monthly price growth was +3.68%, and the average quarterly price growth was +5.50%.
ALC is expected to report earnings on Nov 12, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
ALC | ||
---|---|---|
OUTLOOK RATING 1..100 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 65 | |
SMR RATING 1..100 | 85 | |
PRICE GROWTH RATING 1..100 | 82 | |
P/E GROWTH RATING 1..100 | 73 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALC | BMEZ | |
---|---|---|
RSI ODDS (%) | 1 day ago43% | 1 day ago83% |
Stochastic ODDS (%) | 1 day ago68% | 1 day ago89% |
Momentum ODDS (%) | 1 day ago41% | 1 day ago85% |
MACD ODDS (%) | 1 day ago47% | 1 day ago78% |
TrendWeek ODDS (%) | 1 day ago49% | 1 day ago82% |
TrendMonth ODDS (%) | 1 day ago46% | 1 day ago86% |
Advances ODDS (%) | 11 days ago60% | 11 days ago86% |
Declines ODDS (%) | 1 day ago57% | 1 day ago86% |
BollingerBands ODDS (%) | 1 day ago64% | 1 day ago90% |
Aroon ODDS (%) | 1 day ago50% | 1 day ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BTCZ | 2.83 | 0.09 | +3.10% |
T-Rex 2X Inverse Bitcoin Daily Target ETF | |||
UVIX | 10.54 | 0.19 | +1.84% |
2x Long VIX Futures ETF | |||
TFPN | 24.20 | 0.10 | +0.40% |
Blueprint Chesapeake Multi-Asst Trnd ETF | |||
OCTH | 24.22 | 0.05 | +0.19% |
Innovator Premium Income 20 Bar ETF Oct | |||
ITB | 112.16 | -1.52 | -1.34% |
iShares US Home Construction ETF |
A.I.dvisor indicates that over the last year, BMEZ has been closely correlated with ZBH. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMEZ jumps, then ZBH could also see price increases.
Ticker / NAME | Correlation To BMEZ | 1D Price Change % | ||
---|---|---|---|---|
BMEZ | 100% | -0.97% | ||
ZBH - BMEZ | 67% Closely correlated | -2.06% | ||
ALC - BMEZ | 59% Loosely correlated | -1.12% | ||
TFX - BMEZ | 55% Loosely correlated | -3.39% | ||
GMAB - BMEZ | 53% Loosely correlated | +0.61% | ||
ALNY - BMEZ | 49% Loosely correlated | -1.02% | ||
More |